G Lagrue
About
In The Last Decade
G Lagrue
243 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 131
- Nephrology 896
- Molecular Biology 601
- Physiology 426
- Pulmonary and Respiratory Medicine 346
- Immunology 345
Countries citing papers authored by G Lagrue
This map shows the geographic impact of G Lagrue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Lagrue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Lagrue more than expected).
Fields of papers citing papers by G Lagrue
This network shows the impact of papers produced by G Lagrue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Lagrue. The network helps show where G Lagrue may publish in the future.
Co-authorship network of co-authors of G Lagrue
This figure shows the co-authorship network connecting the top 25 collaborators of G Lagrue. A scholar is included among the top collaborators of G Lagrue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Lagrue. G Lagrue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | Intérêt de la mesure du CO dans l’air expiré dans les maladies vasculaires | 2 |
| 3 | Les thérapies comportementales et cognitives dans l'aide à l'arrêt du tabac : Revue de la littérature et mise au point | 10 |
| 4 | [Nicotine substitution therapy: 10 years later]. | 4 |
| 5 | Quelques réflexions théoriques et pratiques sur les difficultés de l'arrêt du tabac | 3 |
| 6 | [Prevalence of cannabis and tobacco use in patients attending a methadone center. Evaluation by urinary biomarkers]. | 3 |
| 7 | 35 | |
| 8 | 2 | |
| 9 | Oedéme angioneurotique héréditaire: la norgestriénone n'est pas active dans tous les cas. | 2 |
| 10 | 32 | |
| 11 | 12 | |
| 12 | [The effects of prolonged treatment with gliclazide on the course of proteinuria and renal function in diabetic nephropathy]. | 1 |
| 13 | The second component of complement (C2) as an index of hereditary angioneurotic edema. | 1 |
| 14 | Néphropathies glomérulaires primitives et inhalation de substances toxiques. | 8 |
| 15 | [Study of hemostasis factors in nephrotic syndrome. Pathogenic interpretation and therapeutic deductions]. | 6 |
| 16 | [Haptenic function and metabolism of the disaccharides of the glomerular basement membrane in heterologous nephrotoxic antibody-induced glomerulonephritis in rats]. | 1 |
| 17 | [Vascular permeability factor in the supernatant of lymphocyte cultures in subjects with nephrotic syndrome]. | 1 |
| 18 | Le complément sérique. Propriétés biochimiques et modes d'activation. | 1 |
| 19 | [Treatment of primary glomerulopathies with an anti-inflammatory substance: indomethacin]. | 4 |
| 20 | [Trial treatment of various glomerular nephropathies with nitrogen mustards]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.